Cargando…
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis
For over two years, the world has been facing the epidemiological and health challenge of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Growing problems are also complications after the development of COVID-19...
Autores principales: | Dybowska, Małgorzata, Wyrostkiewicz, Dorota, Opoka, Lucyna, Lewandowska, Katarzyna, Sobiecka, Małgorzata, Tomkowski, Witold, Szturmowicz, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499629/ https://www.ncbi.nlm.nih.gov/pubmed/36142282 http://dx.doi.org/10.3390/ijms231810372 |
Ejemplares similares
-
Acute Eosinophilic Pneumonia Complicated with Venous Thromboembolic Disease—Diagnostic and Therapeutic Considerations
por: Jankowska, Ewa, et al.
Publicado: (2022) -
D-Dimers Variability in the Perioperative Period of Breast Cancer Surgery Helps to Predict Cancer Relapse: A Single-Centre Prospective Study
por: Dybowska, Małgorzata, et al.
Publicado: (2023) -
Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
por: Dybowska, Małgorzata, et al.
Publicado: (2020) -
Chronic hypersensitivity pneumonitis is associated with an increased risk of venous thromboembolism: a retrospective cohort study
por: Sobiecka, Małgorzata, et al.
Publicado: (2021) -
New 6-Minute-Walking Test Parameter—Distance/Desaturation Index (DDI) Correctly Diagnoses Short-Term Response to Immunomodulatory Therapy in Hypersensitivity Pneumonitis
por: Lewandowska, Katarzyna B., et al.
Publicado: (2023)